Invesco S&P 500 Revenue ETF (NYSEARCA:RWL) Reaches New 52-Week High – Still a Buy?

Invesco S&P 500 Revenue ETF (NYSEARCA:RWL)’s stock price reached a new 52-week high during trading on Monday . The company traded as high as $130.09 and last traded at $129.39, with a volume of 18913 shares. The stock had previously closed at $128.48.

Invesco S&P 500 Revenue ETF Trading Up 0.3%

The firm has a market cap of $9.39 billion, a price-to-earnings ratio of 18.14 and a beta of 0.85. The firm’s 50 day simple moving average is $126.49 and its two-hundred day simple moving average is $120.91.

Institutional Investors Weigh In On Invesco S&P 500 Revenue ETF

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. GoalVest Advisory LLC raised its holdings in Invesco S&P 500 Revenue ETF by 355.1% in the 4th quarter. GoalVest Advisory LLC now owns 223 shares of the company’s stock valued at $26,000 after acquiring an additional 174 shares in the last quarter. Capital Investment Advisory Services LLC acquired a new stake in shares of Invesco S&P 500 Revenue ETF during the 4th quarter worth approximately $26,000. SWAN Capital LLC bought a new position in Invesco S&P 500 Revenue ETF in the fourth quarter valued at approximately $30,000. Aptus Capital Advisors LLC increased its stake in Invesco S&P 500 Revenue ETF by 359.7% in the fourth quarter. Aptus Capital Advisors LLC now owns 331 shares of the company’s stock valued at $38,000 after acquiring an additional 259 shares during the last quarter. Finally, Tortoise Investment Management LLC bought a new position in Invesco S&P 500 Revenue ETF in the third quarter valued at approximately $39,000.

About Invesco S&P 500 Revenue ETF

RevenueShares Large Cap ETF (the Fund) seeks to achieve its investment objective of outperforming the total return performance of the S&P 500 Index (S&P 500) by investing in the constituent securities of the S&P 500 in the same proportions as the RevenueShares Large Cap Index. The Fund consists of the same constituent securities as the S&P 500. But rather than being weighted by market capitalization, the Fund employs a patent-pending investment methodology to weight stocks by annual revenue. The Fund is rebalanced annually.